Back | Next |
home / stock / pgen / pgen message board
Subject | By | Source | When |
---|---|---|---|
Is there any truth that pgen it looking | noode12 | investorshub | 01/18/2022 1:29:09 PM |
$PGEN Analyst Research NASDAQ | gator16 | investorshub | 12/21/2021 8:10:15 PM |
I am a buyer ! | gator16 | investorshub | 12/13/2021 6:36:28 PM |
Kirk bought 1000000 shares this week !! | gator16 | investorshub | 11/24/2021 5:34:14 PM |
She runnin again | Planopenny | investorshub | 06/11/2021 12:00:30 PM |
A long way to go clinical studies are | make it happen | investorshub | 06/11/2021 11:44:23 AM |
Negative triple digit percent profitability, high negative returns | make it happen | investorshub | 06/11/2021 11:42:52 AM |
https://grabarlaw.com/the-latest/precigen-inc-investigation/ | jgrabar | investorshub | 05/06/2021 2:11:45 PM |
Welcome! | Planopenny | investorshub | 03/01/2021 12:20:32 PM |
IN at $8.3942 | nealhugh | investorshub | 02/28/2021 3:36:24 PM |
More coverage...now stifel @13. | Planopenny | investorshub | 02/25/2021 2:56:01 PM |
Slow claps...bout time. | Planopenny | investorshub | 02/22/2021 6:52:15 PM |
$14 target from Wells Fargo | Planopenny | investorshub | 02/22/2021 1:04:20 PM |
Coverage initiated by Wells Fargo...time for takeoff soon. | Planopenny | investorshub | 02/22/2021 12:34:28 PM |
Coverage initiated by B Riley yesterday with a | Planopenny | investorshub | 02/18/2021 2:26:33 PM |
Look at evfm! That mofo has been running | Planopenny | investorshub | 02/17/2021 4:10:02 PM |
Follow the $$ | Planopenny | investorshub | 02/17/2021 4:00:28 PM |
Wheewf, not sure about that bloated pig, but GLTY! | Porterhouse10 | investorshub | 02/17/2021 3:55:45 PM |
Got some bids in at sndl | Planopenny | investorshub | 02/17/2021 3:44:19 PM |
$PYRNF sorry, Cathy been buying that, but missed it | Porterhouse10 | investorshub | 02/16/2021 5:32:12 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-03 14:30:04 ET Stifel Nicolaus analyst issues MARKET OUTPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Market Outperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst co...
2024-06-03 14:30:03 ET JMP Securities analyst issues UNDERPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Underperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst consensus : B...
Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response PR Newswire – Phase 1/2 pivotal study met the primary safety and efficacy endpoints ...